SEC Form 4 · accession 0001127602-18-009028
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman & CEO · Director
Period of report
Feb 26, 2018
Accepted (ET)
Feb 28, 2018 · 3:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2018 | M | 25,124 | $73.70 | A | 331,238 | D | |
| Common Stock | Feb 26, 2018 | S | 200 | $106.46 | D | 331,038 | D | |
| Common Stock | Feb 26, 2018 | S | 110 | $106.49 | D | 330,928 | D | |
| Common Stock | Feb 26, 2018 | S | 190 | $106.495 | D | 330,738 | D | |
| Common Stock | Feb 26, 2018 | S | 80 | $106.50 | D | 330,658 | D | |
| Common Stock | Feb 26, 2018 | S | 20 | $106.555 | D | 330,638 | D | |
| Common Stock | Feb 26, 2018 | S | 200 | $106.56 | D | 330,438 | D | |
| Common Stock | Feb 26, 2018 | S | 100 | $106.64 | D | 330,338 | D | |
| Common Stock | Feb 26, 2018 | S | 100 | $106.645 | D | 330,238 | D | |
| Common Stock | Feb 26, 2018 | S | 30 | $106.66 | D | 330,208 | D | |
| Common Stock | Feb 26, 2018 | S | 70 | $106.67 | D | 330,138 | D | |
| Common Stock | Feb 26, 2018 | S | 100 | $106.675 | D | 330,038 | D | |
| Common Stock | Feb 26, 2018 | S | 800 | $106.69 | D | 329,238 | D | |
| Common Stock | Feb 26, 2018 | S | 400 | $106.70 | D | 328,838 | D | |
| Common Stock | Feb 26, 2018 | S | 900 | $106.71 | D | 327,938 | D | |
| Common Stock | Feb 26, 2018 | S | 100 | $106.755 | D | 327,838 | D | |
| Common Stock | Feb 26, 2018 | S | 300 | $106.76 | D | 327,538 | D | |
| Common Stock | Feb 26, 2018 | S | 200 | $106.77 | D | 327,338 | D | |
| Common Stock | Feb 26, 2018 | S | 200 | $106.775 | D | 327,138 | D | |
| Common Stock | Feb 26, 2018 | S | 200 | $106.78 | D | 326,938 | D | |
| Common Stock | Feb 26, 2018 | S | 70 | $106.81 | D | 326,868 | D | |
| Common Stock | Feb 26, 2018 | S | 30 | $106.82 | D | 326,838 | D | |
| Common Stock | Feb 26, 2018 | S | 300 | $106.84 | D | 326,538 | D | |
| Common Stock | Feb 26, 2018 | S | 100 | $106.845 | D | 326,438 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $73.70 | Feb 26, 2018 | M | 25,124 | D | Feb 26, 2017 | Feb 26, 2021 | Common Stock | 25,124 | 75,370 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.